For research use only. Not for therapeutic Use.
Udonitrectag (REC 0559), a low molecular weight compound that mimics NGF, aims to address the issue of NGF stability[1].
| Catalog Number | I037798 |
| CAS Number | 1458063-04-1 |
| Synonyms | (1S,4R,5R,7S)-3,4-dibenzyl-2-oxo-6,8-dioxa-3-azabicyclo[3.2.1]octane-7-carboxylic acid |
| Molecular Formula | C20H19NO5 |
| Purity | ≥95% |
| InChI | InChI=1S/C20H19NO5/c22-18-16-17(19(23)24)26-20(25-16)15(11-13-7-3-1-4-8-13)21(18)12-14-9-5-2-6-10-14/h1-10,15-17,20H,11-12H2,(H,23,24)/t15-,16+,17+,20-/m1/s1 |
| InChIKey | SEKGLVUAECPQQM-NHAYFPRASA-N |
| SMILES | C1=CC=C(C=C1)CC2C3OC(C(O3)C(=O)O)C(=O)N2CC4=CC=CC=C4 |
| Reference | [1]. Levi N Kanu, et al. Nerve Growth Factor as an Ocular Therapy: Applications, Challenges, and Future Directions. Semin Ophthalmol. 2021 May 19;36(4):224-231. |
